UCLA scientists build ‘cell villages’ to map the genetics of brain cell fitness
On Aug. 3, 2026, UCLA researchers announced they have grown brain cells from dozens of genetically distinct donors…
-
-
Biotechnology | FDA | Oncology
FDA approves Pluvicto for PSMA+ metastatic hormone-sensitive prostate cancer (mHSPC), advancing potential new standard of care across metastatic disease
On Jul. 31, 2026, Novartis announced the US Food and Drug Administration (FDA) approved Pluvicto® (lutetium Lu 177…
-
Family History Increases Cancer Risk in BRCA-Tested Patients
On Jul. 30, 2026, a study led by Cedars-Sinai Health Sciences University investigators found that women who test…
-
Biotechnology | Imaging | Medical Device | Neurology | Non-Profit Research | Oncology | Therapeutics
UVA Radiology Professors Develop New Focused Ultrasound Approach for Brain Tumors
On Jul. 30, 2026, researchers at the University of Virginia’s (UVA) Department of Radiology and Medical Imaging have…
-
patient receives pioneering lung cancer vaccine in World First
On Jul. 30, 2026, researchers and clinicians from the University of Liverpool and the Clatterbridge Cancer Centre (CCC)…
-
Biotechnology | CDMO | CMO | Medical Device
Resilience and Lilly Invest $750 Million to Increase U.S.-Manufactured Medicine Supply
On Jul. 30, 2026, Resilience, a technology-forward contract development and manufacturing organization dedicated to broadening access to complex…
-
Octapharma to build $1.5 billion state-of-the-art critical care manufacturing facility in Rock Hill, SC
On Jul. 29, 2026, Octapharma, the largest privately owned and independent plasma fractionator in the world, has formally announced plans to establish its first-ever United States-based manufacturing and…
-
FDA Licenses First-Ever Freeze-Dried Plasma Product in the U.S.
On Jul. 29, 2026, the U.S. Food and Drug Administration (FDA) announced it has licensed Ezplaz Freeze Dried…
-
USDA to fund Arizona facility to fight flesh-eating livestock pest
On Jul. 29, 2026, the U.S. Department of Agriculture (USDA) announced it will spend $25 million on a…
-
Biotechnology | Diagnostics | FDA | Oncology
FDA Approves SimpleScreen CRC Blood Test for Colorectal Cancer Screening
On Jul. 28, 2026, The U.S. Food and Drug Administration (FDA) announced it had approved SimpleScreen™ CRC, a…
-
quantum sensor could map single protein structures and lead to breakthroughs in medicine
On Jul. 28, 2026, a research team from the Institute for Quantum Computing (IQC) at the University of…
-
Agriculture | Biotechnology | CDC | Diagnostics | Disease | FDA
Michigan reports 9,253 cyclosporiasis cases as infection outbreak expands
On Jul. 27, 2026, Michigan health officials reported 9,253 cases of cyclosporiasis, an increase of 1,077 cases since…
-
Argenx to Acquire Forte Biosciences for $2.2 billion
On Jul. 27, 2026, argenx, a global immunology innovation company, and Dallas-based Forte Biosciences announced that the companies…
-
Ebola infections in DR Congo surge to 3,200, with 1,405 deaths
On Jul. 27, 2026, the number of people infected with Ebola in the Democratic Republic of the Congo…
-
Blood Proteins May Predict When Genetically At-Risk People Develop ALS
On Jul. 27, 2026, an international research team led by University of Miami Miller School of Medicine scientists…
-
Chinese researchers achieve breakthrough in hybrid rice cloning
On Jul. 26, 2026, Chinese researchers announced they have achieved a major breakthrough in the cloning of hybrid…
-
FDA Approves Tylenol Nonprescription Fixed-Dose Combination of Acetaminophen and Naproxen Sodium for 12-Hour Pain Relief
On Jul. 24, 2026, U.S. Food and Drug Administration (FDA) approved Tylenol with Naproxen (acetaminophen 325 mg/naproxen sodium…
-
Biotechnology | CDC | Diagnostics | Infectious Disease | Measles | NIH | Vaccine
The US Reports More measles cases this year than in all of 2025
On Jul. 24, 2026, the number of measles cases in the U.S. surpassed the record-breaking tally for all…
-
Chinese scientists discover molecular scaffold that enables near-1,000-fold boost in anticancer drug precursor production
On Jul. 24, 2026, a team led by LIAN Jiazhang at Zhejiang University’s College of Chemical and Biological…
-
US CDC links four more states to cyclosporiasis outbreak, Washington Post reports
On Jul. 24, 2026, The U.S. Centers for Disease Control and Prevention has linked four additional states to…
-
Biotechnology | Disease | HIV | Therapeutics | WHO
Merck licenses experimental HIV pill to generic makers in 129 countries
On Jul. 24, 2026, Merck announced it has signed seven voluntary licensing agreements with generic drug manufacturers to…
-
Otsuka Receives FDA Approval for First-in-Class SIMTRIYO® (centanafadine) for Treatment of ADHD
On Jul. 24, 2026, Otsuka Pharmaceutical announced that the U.S. Food and Drug Administration (FDA) has granted approval…
-
U.S. FDA investigates another cyclosporiasis outbreak
On Jul. 22, 2026, The U.S. Food and Drug Administration (FDA) announced it is investigating a new outbreak…
-
FDA Approves Johnson & Johnson Market Authorization for OTTAVA™ Robotic Surgical System in the U.S.
On Jul. 22, 2026, Johnson & Johnson announced that the U.S. Food and Drug Administration (FDA) has granted…
-
OraSure Receives Emergency Use Authorization for Second Generation Ebola Test
On Jul. 21, 2026, OraSure Technologies announced that it has received Emergency Use Authorization (EUA) from the U.S….
-
Ebola death toll in Congo Exceeds 930, including dozens of health workers
On Jul. 20, 2026, the death toll in Congo’s Ebola outbreak has risen to at least 930, the…
-
Tempus to Acquire Personalis for $1.5 Billion
On Jul. 20, 2026, Tempus AI, a technology company leading the adoption of AI to advance precision medicine…
-
Bristol Myers Squibb to Build the Most Powerful AI Factory in Life Sciences with NVIDIA
On Jul. 20, 2026, Bristol Myers Squibb announced it will expand its compute infrastructure to deploy an NVIDIA…
-
Scientists map how the flu virus rewires the human cell from the inside
On Jul. 20, 2026, researchers at EMBL Hamburg and collaborators at the Leibniz Research Institute for Molecular Pharmacology…
-
Researchers Generate red blood cell-like cells from canine iPSCs
On Jul. 20, 2026, a research group led by Osaka Metropolitan University (OMU) using dog iPS cells announced…
